Literature DB >> 26079822

Upper reference limits for cerebrospinal fluid total protein and albumin quotient based on a large cohort of control patients: implications for increased clinical specificity.

Harald Hegen, Michael Auer, Achim Zeileis, Florian Deisenhammer.   

Abstract

BACKGROUND: Determination of cerebrospinal fluid (CSF) total protein (TP) as well as of CSF/serum albumin quotient (Qalb) is part of the routine CSF work-up. However, currently used upper reference limits (URL) are not well validated leading to over-reporting of blood-CSF barrier dysfunction in approximately 15% of patients without neurological disease. The objective of this study was to determine age-related URL for CSF TP and Qalb in a cohort of control patients.
METHODS: A total of 332 paired CSF and serum samples of patients without objective clinical and paraclinical findings of a neurological disease were analyzed for CSF TP and Qalb. CSF TP was measured by spectrophotometry and albumin in CSF and serum by nephelometry.
RESULTS: CSF TP concentration and Qalb significantly correlated with age. In subjects at the age of 18-70 years, median CSF TP ranged from 320 to 460 mg/L and URL defined as the 95th percentile were 530-690 mg/L. Median Qalb ranged from 4.1 to 6.1 and URL from 8.7 up to 11.0. For URL of Qalb we calculated the following formula: age/25+8.
CONCLUSIONS: Age-dependent URL for CSF TP and Qalb are presented here in a large cohort of control patients. They are higher than those currently recommended and this probably explains why isolated blood-CSF barrier dysfunction has been apparently over-reported. These new URL might be considered in a future revision of CSF guidelines.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26079822     DOI: 10.1515/cclm-2015-0253

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  22 in total

Review 1.  Cerebrospinal fluid analysis and the determination of oligoclonal bands.

Authors:  Matteo Gastaldi; Elisabetta Zardini; Rosaria Leante; Maddalena Ruggieri; Gianna Costa; Eleonora Cocco; Giovanna De Luca; Ivana Cataldo; Tiziana Biagioli; Clara Ballerini; Massimiliano Castellazzi; Enrico Fainardi; Paola Pettini; Mauro Zaffaroni; Debora Giunti; Elisabetta Capello; Gaetano Bernardi; Emilio Ciusani; Claudia Giannotta; Eduardo Nobile-Orazio; Elena Bazzigaluppi; Gabriella Passerini; Roberta Bedin; Patrizia Sola; Rinaldo Brivio; Guido Cavaletti; Arianna Sala; Antonio Bertolotto; Gaetano Desina; Maurizio A Leone; Sara Mariotto; Sergio Ferrari; Andreina Paternoster; Davide Giavarina; Francesco Lolli; Diego Franciotta
Journal:  Neurol Sci       Date:  2017-10       Impact factor: 3.307

2.  Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology.

Authors:  Pierre R Bourque; J Brooks; J Warman-Chardon; A Breiner
Journal:  J Neurol       Date:  2019-11-16       Impact factor: 4.849

3.  Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers.

Authors:  Cristina Parrado-Fernández; Kaj Blennow; Magnus Hansson; Valerio Leoni; Angel Cedazo-Minguez; Ingemar Björkhem
Journal:  J Cell Mol Med       Date:  2018-07-27       Impact factor: 5.310

4.  Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.

Authors:  M N Olesen; K Soelberg; B Debrabant; A C Nilsson; S T Lillevang; J Grauslund; I Brandslund; J S Madsen; F Paul; T J Smith; S Jarius; N Asgari
Journal:  J Neuroinflammation       Date:  2019-03-11       Impact factor: 8.322

5.  Dataset for worldwide survey of cerebrospinal total protein upper reference values.

Authors:  Pierre R Bourque; John Brooks; Jodi Warman-Chardon; Harald Hegen; Florian Deisenhammer; Chris R McCudden; Ari Breiner
Journal:  Data Brief       Date:  2019-03-07

6.  Causes of albuminocytological dissociation and the impact of age-adjusted cerebrospinal fluid protein reference intervals: a retrospective chart review of 2627 samples collected at tertiary care centre.

Authors:  John Alexander Brooks; Christopher McCudden; Ari Breiner; Pierre R Bourque
Journal:  BMJ Open       Date:  2019-02-13       Impact factor: 2.692

Review 7.  The Cerebrospinal Fluid in Multiple Sclerosis.

Authors:  Florian Deisenhammer; Henrik Zetterberg; Brit Fitzner; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

8.  Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric Study.

Authors:  Klaus Berek; Gabriel Bsteh; Michael Auer; Franziska Di Pauli; Anne Zinganell; Thomas Berger; Florian Deisenhammer; Harald Hegen
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

9.  High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Authors:  Qing Li; Jinglong Chen; Mengzhuo Yin; Jun Zhao; Fuchang Lu; Zhanhang Wang; Xiaoqi Yu; Shuangyan Wang; Dong Zheng; Honghao Wang
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

Review 10.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.